CVR number 41304413
Industry 47.9111 Retail sale via mail order houses or via Internet

BioItalia ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 12.3% 9.3% 12.2%  
Credit score (0-100)  0 0 18 26 18  
Credit rating  N/A N/A BB BB BB  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -38.8 3.5 2.8  
EBITDA  0.0 0.0 -38.8 3.5 2.8  
EBIT  0.0 0.0 -47.1 -7.6 -8.2  
Pre-tax profit (PTP)  0.0 0.0 -47.4 -9.8 -11.8  
Net earnings  0.0 0.0 -37.7 -7.7 -9.2  
Pre-tax profit without non-rec. items  0.0 0.0 -47.4 -9.8 -11.8  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 2.3 -5.3 -14.5  
Interest-bearing liabilities  0.0 0.0 49.5 52.9 49.7  
Balance sheet total (assets)  0.0 0.0 56.8 47.9 35.2  
Net Debt  0.0 0.0 49.5 52.9 49.7  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -38.8 3.5 2.8  
Gross profit growth  0.0% 0.0% 0.0% 0.0% -18.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 57 48 35  
Balance sheet change%  0.0% 0.0% 0.0% -15.8% -26.4%  
Added value  0.0 0.0 -38.8 0.7 2.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 39 -22 -22  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 121.4% -220.1% -293.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -82.8% -13.8% -16.0%  
ROI %  0.0% 0.0% -90.8% -14.5% -16.1%  
ROE %  0.0% 0.0% -1,613.8% -30.5% -22.1%  

Solidity 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  0.0% 0.0% 4.1% -10.0% -29.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -127.6% 1,531.5% 1,770.8%  
Gearing %  0.0% 0.0% 2,120.7% -992.2% -342.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 1.5% 4.3% 6.9%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.0 0.0 0.2 0.2 0.2  
Current Ratio  0.0 0.0 0.2 0.2 0.2  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -44.6 -41.3 -39.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0